Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We historically created next generation immunotherapies using breakthrough de novo protein design technology. In December 2023, the previously announced merger between Neurogene Inc and Neoleukin Therapeutics (NGNE) was completed. Neurogene is a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases. For more information about the Neurogene, please visit www.neurogene.com, @NeurogeneInc on X (formerly Twitter) or @Neurogene Inc on LinkedIn.
View Top Employees from Neoleukin Therapeutics| Website | https://www.neurogene.com/ |
| Employees | 52 (52 on RocketReach) |
| Founded | 2019 |
| Address | 1616 Eastlake Ave E 360, Seattle, Washington 98102, US |
| Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Drug Discovery, Science and Engineering, Pharmaceuticals, Medical, Health Care |
Looking for a particular Neoleukin Therapeutics employee's phone or email?
Neoleukin Therapeutics Questions
Brett Stewart is the Director of IT of Neoleukin Therapeutics.
52 people are employed at Neoleukin Therapeutics.
Neoleukin Therapeutics is based in Seattle, Washington.
Top Neoleukin Therapeutics Employees
-
View
Priti Patel
Chief Medical Officer at Neoleukin Therapeutics
Menlo Park, California, United States33 -
32
-
54
-
ViewChristine Burnett
Senior Director, Clinical Science at Neoleukin Therapeutics
New Jersey, United States33 -
ViewAakar Shah
Senior Director, Head of Statistical Programming at Neoleukin Therapeutics
California, United States34
Related Companies
